Low DDR1 expression tends to lead to a poor disease-free survival rate in triple-negative breast cancer patients (Koh et al., 2015) and is associated with poor prognosis in lung cancer patients (Ford et al., 2007). The gene discussed is DDR1; the disease is lung carcinoma.